of this economic appraisal, I feci that this is an important issue which the authors could have elaborated upon further in the discussion.
It is clear that considerable savings would accrue from the development of a test to distinguish patients with Gram-negative sepsis. Indeed, sensitivity analysis was used to good effect to determine the likely cost-effectiveness ratios for different test performance characteristics. Furthermore, as the authors point out, if a target level of costeffectiveness was sought before the test could be adopted, the probability of disease needed to Errata Pho.rmaco£ conom ics 1 (1) 1993 achieve this degree of efficiency could be regarded as the threshold for treatment. This would be of value in aiding decisions about the value of a test when it is ultimately developed. Herein lies the great strength of this paper, inasmuch as it will serve to guide the implementation of this new and apparently costly drug at both local and national levels.
